Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis
Yong Huang(University of Chicago), Imre Noth(University of Chicago), Kevin R. Flaherty(Pulmonary and Critical Care Associates), Rekha Vij(University of Chicago), Bethany B. Moore(Michigan Medicine), MeiLan K. Han(University of Michigan), Joe G. N. Garcia(Johns Hopkins University), Eric S. White(University of Michigan–Ann Arbor), Tong Zhou(Hangzhou Cancer Hospital), John R. Erb‐Downward(University of Michigan), Shwu‐Fan Ma(University of Chicago), Yves A. Lussier(University of Arizona), Cory M. Hogaboam(University of Michigan–Ann Arbor), Gary B. Huffnagle(University of Michigan), Naftali Kaminski(Yale University), Jiànróng Lǐ(University of Arizona), Milena S. Espíndola(Cedars-Sinai Medical Center), Fernando J. Martínez(University of Michigan–Ann Arbor), Justin M. Oldham(University of Michigan)
Cited by 140
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k